Lucid Diagnostics LUCD
NASDAQ LUCD
$0.96 -0.05 (-4.70%)
At close: Aug 20, 2026 · 1:17 PM UTC

Lucid Diagnostics (LUCD) Non Operating Income (2025 - 2026)

Lucid Diagnostics' (LUCD) quarterly Non Operating Income came in at -$1.8 million in Q1 2026, up 87.55% YoY from -$957063.4 in Q1 2025, and up 87.55% on a QoQ basis from -$14.4 million in Q1 2025.

Lucid Diagnostics (LUCD) Non Operating Income (2025 - 2026) Analysis & Trends

Lucid Diagnostics (LUCD) has 2 years of Non Operating Income data on file, last reported at -$1.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn -
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 46.00 Mn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn -
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn -
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 6.60 Mn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn -
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn -12.30 Mn
10 Lucid Diagnostics 176.26 Mn 142.85 Mn 55,000.00 1.11 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Mn
Mar 31, 2026 -1.80 Mn
Mar 31, 2025 -14.42 Mn